News • Blogs • Videos •
Forward to Friend
NSP Logo
Nicotine Science and Policy
Daily Digest - Wednesday, 25 May 2016

More than half of EU citizens questioned now think e-cigarettes [...]

More than half of Europeans now think that e-cigarettes are harmful--a proportion that has nearly doubled in two years--show the latest results of a European Union (EU)-wide survey, [...] The researchers analysed responses to two Eurobarometer for Tobacco surveys carried out in early 2012 and late 2014, [...]


Schizophrenia link to smoking during pregnancy found

A baby's chances of developing schizophrenia during later life is heightened by smoking during pregnancy, a study suggests. Research in Finland found that the more women were exposed to nicotine the greater chance they had of having a child affected by the severe mental illness. Signs of heavy nicotine exposure in a mother's blood were associated with a 38% increased likelihood of schizophrenia.


Researchers raise concerns over e-cig safety

Thousands of electronic cigarette users are risking dangerous levels of lung inflammation, the first study of its kind has revealed. Dr Andrew Higham from The University of Manchester says the vapour which e-smokers inhale contains formaldehyde and acrolein—similar to traditional cigarettes—which could be harmful if taken over the long term.


E-cigarette marketing linked to teen e-cigarette use

Using data from the 2014 National Youth Tobacco Survey, researchers found that youth were exposed to e-cigarette marketing messages through many channels: retail settings, internet, print, television and movies. Of the 22,007 middle and high school students who were surveyed, 20 percent had tried e-cigarettes before and 9 percent were current users.


Axa to divest €1.8bn of tobacco investments

Insurer AXA plans to divest €1.8bn (£1.4bn) of tobacco investments and called upon rivals to do the same, citing the industry’s “tragic” impact on public health. The announcement by one of the world’s top investment institutions is the second major blow for UK tobacco firms inside a week, after the high court rejected their legal challenge against plain packaging.


Europe lifts warning on Pfizer smoking cessation drug

European regulators have lifted a warning on Pfizer's smoking cessation drug Champix - called Chantix in the United States - after a clinical study concluded it did not appear to increase the risk of neuropsychiatric side effects. Champix is approved as an effective therapy for helping smokers quit but the European Medicines Agency added a "black triangle" warning [...]


Visit "" for more news
Global Forum on Nicotine 2016 -
Copyright © 2016 Nicotine Science and Policy, All rights reserved.

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by MailChimp